Community-reported outcomes and benefit framing are inference from per-component data
And yep, nuut fits right into that game plan
FDA GLP-1 Telehealth Marketing Warning Announcement In addition to Hims & Hers, these new set of warnings were sent to telehealth companies selling GLP-1 Weight Loss solutions, including: MaxLife, Measured, Zappy, Kin Meds, GoodGirlRx, WeightCare and PharmaZee among others
At its highest dose, 36 mg, participants in a phase 3 trial lost an average of 12.4 percent of their starting weight over 72 weeks
These services typically include: Video visits with board-certified clinicians Ongoing follow-up and check-ins Access to care teams and registered dietitians Meal plans and lifestyle changes guidance Some programs also bundle medication, supplements, and wellness coaching into a full weight loss journey
This raised questions about whether GLP-1RAs could cause pancreatic effects beyond pancreatitis, including the development of PDAC